Bristol-myers Squibb Compnay

Lynn Abell

R Michael Lawrence

Heather J Finlay

Jennifer X Qiao

Tammy C Wang

Jon J Hangeland

Todd J Friends

Cullen L Cavallaro

Carol Hui Hu

Leonard Adam

John E Lloyd

George O Tora

Zulan Pi

Ji Jiang

Ji Jang

The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments. The disclosure also provides a novel method of treating diseases or conditions related to the activity of endothelial lipase by use of compounds according to Formula (II): as defined in the specification and compositions comprising any of the compounds. 

Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors

The present invention provides compounds of Formula (I) or Formula (III): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.

The present invention provides compounds of Formula (I) or Formula (III): [INSERT CHEMICAL STRUCTURE HERE] (I) [INSERT CHEMICAL STRUCTURE HERE] (III) as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments. 

Growing community of inventors

Washington Crossing, PA, United States of America

Lynn Abell